Phase 3CompletedAge-related condition

Age-Related Eye Disease Study (AREDS)

Sponsor
National Eye Institute (NEI) (NIH)
Enrollment
4,757 enrolled
Conditions
Macular Degeneration; Cataract; Lens Opacities
Interventions
Antioxidants; Zinc; Antioxidants and zinc
Ages
adults, older adults
Registry
NCT00000145

Full record on ClinicalTrials.gov

From the registry

To assess the clinical course, prognosis, and risk factors of age-related macular degeneration (AMD) and cataract. To evaluate, in randomized clinical trials, the effects of pharmacologic doses of (1) antioxidants and zinc on the progression of AMD and (2) antioxidants on the development and progression of lens opacities.

Primary outcomes

  • Progression of age-related macular degeneration
  • Progression of lens opacity (cataract)

History

  1. Last registry update

  2. Study completion

  3. Primary completion

  4. Registered

  5. Started

Papers citing this trial